Chinese researchers have identified a bat coronavirus that shares a key trait with the virus behind Covid-19—it uses the same ACE2 receptor to invade human cells. While this raises concerns about potential future transmission, experts caution against alarm, as the virus currently shows limited ability to infect humans.
The study, published in the journal Cell, reveals that HKU5-CoV-2 possesses a furin cleavage site—a feature also found in Sars-CoV-2 that facilitates cell entry. However, lab tests confirm it infects human cells far less efficiently than its pandemic-causing cousin.
"This discovery helps us understand how coronaviruses evolve," said lead researcher Dr. Li Wenliang. "But our data shows HKU5-CoV-2 binds weakly to human ACE2 compared to Sars-CoV-2." The team successfully tested monoclonal antibodies and existing antivirals against the new virus.
The research made waves in financial markets when reported by Bloomberg last Friday (Feb 21). Shares of major vaccine developers rose despite broader market declines—Pfizer gained 1.5%, Moderna jumped 5.3%, and Novavax increased about 1%.
"The reaction is overblown," commented Dr. Michael Osterholm of University of Minnesota regarding pandemic concerns. "Population immunity against similar viruses has significantly improved since 2019."
Why Experts Aren't Worried (Yet)
The virus demonstrates poor adaptation for human-to-human transmission
Existing treatments show effectiveness in lab settings
Widespread immunity from prior infections provides protection
The research team emphasized their findings should not cause undue concern: "While surveillance remains important, multiple biological barriers currently prevent this virus from becoming another Sars-CoV-2." Their paper concludes that while HKU5-CoV-2 warrants monitoring, its emergence risk appears limited based on current evidence.
Related Research:
